About This Calculator

The High-Dose Insulin Euglycemia (HIE) Therapy calculator is designed for clinicians to determine initial dosing for HIE, a critical intervention for managing severe toxicity from calcium channel blockers (CCBs) and beta-blockers (BBs). This therapy counteracts myocardial depression and vasodilation by improving cardiac contractility and energy utilization. This tool simplifies the calculation of insulin and dextrose boluses and infusions based on patient weight and available drug concentrations.

Understanding the Outputs

After entering the necessary patient and drug information, the calculator provides the following key values for administration:

  • Insulin Bolus: The total volume of regular insulin (in units) to be administered as an initial intravenous push.
  • Insulin Infusion: The total dose (units/hr) and the corresponding pump rate (mL/hr) based on the specified insulin concentration.
  • Dextrose Bolus: The total dose (grams) and the volume (mL) of the selected dextrose solution to administer. This is often given to prevent hypoglycemia from the initial insulin bolus.
  • Dextrose Infusion: The required rate (g/hr) and the corresponding pump rate (mL/hr) needed to maintain euglycemia (target blood glucose 100-200 mg/dL or 5.5-11.1 mmol/L).

How to Use the Tool

Follow these steps to ensure accurate dosing calculations:

  1. Enter Patient Weight: Input the patient's weight and select the correct unit (kg or lbs). The tool will use the weight in kg for all calculations.
  2. Confirm Insulin Doses: The tool defaults to standard starting doses (1 unit/kg bolus, 1 unit/kg/hr infusion). Adjust these values if your institutional protocol differs.
  3. Select Insulin Concentration: Choose the available insulin infusion preparation from the dropdown. If using a non-standard concentration, select "Custom" and enter the units and total volume (mL).
  4. Confirm Dextrose Doses: Verify the initial dextrose bolus and infusion doses. These are optional but highly recommended. Select the available dextrose concentrations for both the bolus (e.g., D50W) and the continuous infusion (e.g., D10W).
  5. Review Results: The calculator automatically generates the required doses and infusion rates for immediate clinical use. Always double-check calculations before administration.

Dosing Overview

HIE therapy is initiated with a bolus of regular insulin (typically 1 unit/kg), followed by a continuous infusion (starting at 1 unit/kg/hr). The primary goal is to improve hemodynamic parameters, such as mean arterial pressure and cardiac output. The insulin infusion should be titrated upwards every 30-60 minutes based on clinical response, with rates of up to 10 units/kg/hr used in severe, refractory cases. Throughout therapy, a concurrent dextrose infusion is essential to maintain euglycemia and avoid hypoglycemia.

Switching & Combination Therapy

HIE is a primary treatment for severe CCB and BB poisoning and is often used when initial therapies like intravenous fluids, calcium, and glucagon are insufficient. It can be used concurrently with vasopressors (e.g., norepinephrine), and successful HIE therapy may allow for the weaning of catecholamine support. The decision to switch from or add to existing therapies should be based on ongoing hemodynamic assessment.

Missed Dose Protocol

The concept of a "missed dose" does not apply to HIE therapy. HIE is a continuous intravenous infusion administered in a critical care setting for an acute toxicological emergency. The infusion rate is actively managed and titrated by the clinical team based on the patient's real-time hemodynamic and metabolic status, not a fixed schedule.

Safety Alerts

Critical Monitoring Required

  • Hypokalemia: HIE drives potassium into cells, causing a rapid drop in serum levels. This can lead to life-threatening arrhythmias. Monitor potassium every 1-2 hours initially and replace it aggressively to maintain levels > 2.8 mEq/L.
  • Hypoglycemia: Frequent blood glucose monitoring is mandatory (every 15-30 minutes for the first hour, then hourly). The dextrose infusion must be adjusted to maintain blood glucose in the target range (100-200 mg/dL).
  • Central Line Access: Dextrose solutions with a concentration greater than 12.5% (e.g., D20W, D50W) are hyperosmolar and can cause severe tissue injury if extravasation occurs. Administer these concentrations through a central venous catheter.

Frequently Asked Questions

Can I use this calculator for diabetic ketoacidosis (DKA)?

No. This calculator is specifically designed for the high doses used in toxicologic emergencies (HIE therapy), which are much higher than those used for DKA. DKA management requires different protocols and therapeutic goals.

Why is the default insulin dose 1 unit/kg?

A starting dose of 1 unit/kg (bolus and infusion) is the most commonly cited and studied dose in clinical literature for initiating HIE therapy. It provides a balance of efficacy and safety, with titration based on patient response.

What should I do if the patient becomes hypoglycemic?

Immediately administer a bolus of intravenous dextrose (e.g., 25g of D50W for an adult) and increase the rate of the dextrose infusion. Glucose levels must be re-checked frequently (e.g., every 15 minutes) until they have stabilized in the target range.

Is a central line always required for HIE therapy?

While HIE can be started via peripheral IVs, a central line is strongly recommended. It is essential for the safe administration of high-concentration dextrose infusions (>12.5%), allows for frequent lab draws, and provides reliable access for other necessary medications and hemodynamic monitoring.

Why does the calculator have an option for custom insulin concentrations?

Hospitals may prepare insulin infusions in various concentrations. The "Custom" option provides the flexibility to perform accurate pump rate calculations regardless of the specific preparation available at your institution.

How long is HIE therapy continued?

Therapy is typically continued until hemodynamic stability is achieved and the underlying toxicity has resolved, which may take 24-48 hours or longer depending on the substance ingested (e.g., sustained-release formulations). Weaning should be done slowly once vasopressor support is minimal or off.

What are the primary therapeutic goals of HIE?

The main goals are to improve cardiac contractility (inotropy) and reverse vasodilation-induced shock. This is achieved by providing the heart with a readily available energy substrate (glucose, facilitated by insulin) and overcoming insulin resistance caused by the overdose.

What if my hospital doesn't have D50W for the bolus?

The calculator allows you to select other concentrations like D25W or D10W. The tool will calculate the larger volume required to deliver the same gram dose of dextrose. Always be mindful of the total fluid volume being administered.

References

  • Engebretsen, K. M., Kaczmarek, K. M., & Morgan, J. (2011). High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clinical Toxicology, 49(4), 277–283. https://doi.org/10.3109/15563650.2011.582471
  • St-Onge, M., Anseeuw, K., Cantrell, F. L., et al. (2017). Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults. Critical Care Medicine, 45(3), e306–e315. https://doi.org/10.1097/CCM.0000000000002087
  • Cole, J. B., Arens, A. M., Laes, J. R., et al. (2018). High dose insulin for beta-blocker and calcium channel-blocker poisoning: A systematic review. The American Journal of Emergency Medicine, 36(10), 1817–1824. https://doi.org/10.1016/j.ajem.2018.02.004
  • Greene, S. L., Gawarammana, I., Wood, D. M., Jones, A. L., & Dargan, P. I. (2007). Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study. Intensive Care Medicine, 33(11), 2019–2024. https://doi.org/10.1007/s00134-007-0763-y
PRO
Ad-Free Access
$3.99 / month
  • ✓ No Interruptions
  • ✓ Faster Page Loads
  • ✓ Support Content Creators
Subscribe Now